Brief: Organogenesis President And Chief Executive Officer Gary S. Gillheeney, Sr. Elected Chair Of The Board Of Directors
27/04/2023 13:59
April 27 (Reuters) - Organogenesis Holdings Inc
ORGO.O :
* ORGANOGENESIS PRESIDENT AND CHIEF EXECUTIVE OFFICER GARY
S.
GILLHEENEY, SR. ELECTED CHAIR OF THE BOARD OF DIRECTORS
* ORGANOGENESIS HOLDINGS INC - ELECTED PRESIDENT AND CHIEF
EXECUTIVE OFFICER GARY S. GILLHEENEY, SR., AS CHAIR OF BOARD,
EFFECTIVE IMMEDIATELY
* ORGANOGENESIS HOLDINGS INC - GILLHEENEY WILL CONTINUE IN
HIS
ROLE AS PRESIDENT AND CHIEF EXECUTIVE OFFICER
Source text for Eikon: ID:nGNX36ql3M
Further company coverage: ORGO.O
((Reutersbriefs@thomsonreuters.com;))
Recent news on Organogenesis Holdings
See all newsBrief: Organogenesis Announces Publication Of Peer-Reviewed Prepare Trial Results
Organogenesis Holdings Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Organogenesis Q2 Net Product Revenue USD 42.8 Million
Organogenesis Holdings Inc. expected to post a loss of 35 cents a share - Earnings Preview
Brief: Organogenesis Announces Publication Of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit Of Affinity™ In The Most Challenging And Complex Venous Leg Ulcers